Parameswaran Hari

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial”.

Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100361

N/A

1.6DataRank · unranked

38 citations

Anikó Szabó, Kathryn E. Flynn, Binod Dhakal, Saurabh Chhabra, Marcelo C. Pasquini +3 more

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Haematologica(2020)10.3324/haematol.2020.248187

N/A

1.3DataRank · unranked

39 citations

Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey +30 more

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Nature Medicine(2020)10.1038/s41591-020-1081-3

N/A

0.921DataRank · unranked

464 citations

Bryon D. Johnson, Dina Schneider, Fenlu Zhu, Anikó Szabó, Carolyn A. Keever-Taylor +11 more

Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy

Communications Medicine(2022)10.1038/s43856-022-00116-5

N/A

0.616DataRank · unranked

16 citations

Anikó Szabó, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett +11 more

Bortezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light chain amyloidosis (AL): A study of 426 patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8515

N/A

0.165DataRank · unranked

2 citations

Parameswaran Hari, Stacey Goodman, Luciano J. Costa, Raphael Fraser, Noel Estrada‐Merly +4 more

Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.01.010

N/A

0DataRank · unranked

15 citations

Saurabh Chhabra, Noa Biran, Arnab Chowdhury, Parameswaran Hari, Amrita Krishnan +2 more

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

Bone Marrow Transplantation(2020)10.1038/s41409-020-0887-4

N/A

0DataRank · unranked

44 citations

Simona Iacobelli, Marcelo C. Pasquini, Riddhi Modi, Luisa Giaccone, Joan Bladé +13 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

UNC Libraries(2020)10.17615/0d7e-cz27

N/A

0DataRank · unranked

0 citations

Robert A. Kyle, Heather J. Landau, Siddhartha Ganguly, Anita D’Souza, Brendan M. Weiss +25 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01217-9

N/A

0DataRank · unranked

14 citations

Yan Cheng, Jesse D. Riordan, Adam J. Dupuy, Wendy Dubois, Michael Pisano +6 more

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.013

N/A

0DataRank · unranked

707 citations

Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra +16 more

The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7003

N/A

0DataRank · unranked

2 citations

Qaiser Bashir, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +11 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1

N/A

0DataRank · unranked

1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

American Journal of Hematology(2022)10.1002/ajh.26596

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Edward A. Stadtmauer, Marcelo C. Pasquini, Parameswaran Hari, Asad Bashey +16 more

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.007

N/A

0DataRank · unranked

9 citations

T Nishihori, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +15 more

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad386

N/A

0DataRank · unranked

13 citations

Drew J. Winston, Scott D. Rowley, Kathleen M. Mullane, Pranatharthi Chandrasekar, Parameswaran Hari +14 more

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

Haematologica(2023)10.3324/haematol.2022.282269

N/A

0DataRank · unranked

5 citations

Mei-Jei Zhang, Linda J. Burns, Xiaoying Tang, Christa L. Meyer, Lih‐Wen Mau +18 more

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

Research Square(2023)10.21203/rs.3.rs-3318127/v1

N/A

0DataRank · unranked

1 citations

Jeries Kort, Leland Metheny, Pingfu Fu, Parameswaran Hari, Gen Li +8 more

Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance

Leukemia(2023)10.1038/s41375-023-02078-6

N/A

0DataRank · unranked

0 citations

Shahram Arsang‐Jang, Ben Massat, Bicky Thapa, Victoria Patek, Anita D’Souza +7 more

Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing

Blood Cancer Journal(2024)10.1038/s41408-024-01024-8

N/A

0DataRank · unranked

7 citations

Shahram Arsang‐Jang, Yan Cheng, Fumou Sun, Anita D’Souza, Binod Dhakal +11 more

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.053

N/A

0DataRank · unranked

4 citations

Jeries Kort, Leland Metheny, Pingfu Fu, Gen Li, Parameswaran Hari +8 more

Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History

New England Journal of Medicine(2025)10.1056/nejmc2415164

N/A

0DataRank · unranked

14 citations

Lynn Malec, Myriam Armant, Bryon D. Johnson, Qizhen Shi, Huiqing Xu +12 more

SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopenia

Research Square(2021)10.21203/rs.3.rs-462080/v1

N/A

0DataRank · unranked

6 citations

Yongwei Zheng, Mei Yu, Jianhui Wei, Yongguang Zhang, Paytsar Topchyan +12 more

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

Clinical Infectious Diseases(2020)10.1093/cid/ciz1210

N/A

0DataRank · unranked

111 citations

Lynn El Haddad, Drew J. Winston, Scott D. Rowley, Kathleen M Mulane, Pranatharthi Chandrasekar +13 more

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Blood Advances(2020)10.1182/bloodadvances.2019000765

N/A

0DataRank · unranked

51 citations

J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza +9 more

Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000915

N/A

0DataRank · unranked

20 citations

Mary L. Faber, Theodore R. Keppel, Amanda R. Buchberger, Matthew Waas, Parameswaran Hari +3 more

Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.11.018

N/A

0DataRank · unranked

18 citations

Raphael Fraser, Luciano J. Costa, Stacey Goodman, Noel Estrada‐Merly, Cindy Lee +20 more